<?xml version="1.0" encoding="UTF-8"?>
<html xmlns="http://www.w3.org/1999/xhtml">
 <head charset="UTF-8"/>
 <style> * { font-family : helvetica;} .font16 { font-size : 16; } .font10 { font-size : 10; } .font27 { font-size : 27; } .font11 { font-size : 11; } .font12 { font-size : 12; } .font13 { font-size : 13; } .font30 { font-size : 30; } .font14 { font-size : 14; } .font15 { font-size : 15; }</style>
 <body>
  <p>
   <span class="font30">the </span>
   <span class="font27">and </span>
   <span class="font16">for </span>
   <span class="font15">HBV </span>
   <span class="font15">hepatitis </span>
   <span class="font14">transmission </span>
   <span class="font14">with </span>
   <span class="font14">pregnancy </span>
   <span class="font14">were </span>
   <span class="font14">meta-analysis </span>
   <span class="font13">trimester </span>
   <span class="font13">MTCT </span>
   <span class="font13">third </span>
   <span class="font13">{background </span>
   <span class="font13">network </span>
   <span class="font12">antiviral </span>
   <span class="font12">was </span>
   <span class="font12">pregnant </span>
   <span class="font12">treatment </span>
   <span class="font12">during </span>
   <span class="font12">safety </span>
   <span class="font12">efficacy </span>
   <span class="font12">non-RCTs </span>
   <span class="font12">margin </span>
   <span class="font12">{border-style </span>
   <span class="font12">The </span>
   <span class="font12">high </span>
   <span class="font12">late </span>
   <span class="font12">preventing </span>
   <span class="font12">px;} </span>
   <span class="font12">#ffffff;} </span>
   <span class="font12">AVT </span>
   <span class="font12">agents </span>
   <span class="font12">different </span>
   <span class="font12">from </span>
   <span class="font12">telbivudine </span>
   <span class="font11">maternal </span>
   <span class="font11">that </span>
   <span class="font11">virus </span>
   <span class="font11">control </span>
   <span class="font11">data </span>
   <span class="font11">prevent </span>
   <span class="font11">risk </span>
   <span class="font11">second </span>
   <span class="font11">timing </span>
   <span class="font11">Fig. </span>
   <span class="font11">RCTs </span>
   <span class="font11">analysis </span>
   <span class="font11">studies </span>
   <span class="font11">therapy </span>
   <span class="font11">viral </span>
   <span class="font11">chronic </span>
   <span class="font11">(Fig. </span>
   <span class="font11">DNA </span>
   <span class="font11">HBeAg </span>
   <span class="font11">among </span>
   <span class="font11">non-RCTs: </span>
   <span class="font11">versus </span>
   <span class="font11">vertical </span>
   <span class="font11">compared </span>
   <span class="font11">have </span>
   <span class="font11">Hepatol </span>
   <span class="font11">Viral </span>
   <span class="font11">[]. </span>
   <span class="font11">level </span>
   <span class="font11">mother-to-child </span>
   <span class="font11">mothers </span>
   <span class="font11">perinatal </span>
   <span class="font11">significant </span>
   <span class="font11">Gastroenterol </span>
   <span class="font11">Hepat </span>
   <span class="font11">after </span>
   <span class="font11">al.Efficacy </span>
   <span class="font11">due </span>
   <span class="font11">female </span>
   <span class="font11">first </span>
   <span class="font11">had </span>
   <span class="font11">mother-to-infant </span>
   <span class="font11">provided </span>
   <span class="font11">than </span>
   <span class="font11">trimester, </span>
   <span class="font11">trimesters </span>
   <span class="font11">week </span>
   <span class="font11">which </span>
   <span class="font11">women </span>
   <span class="font10">MTCT. </span>
   <span class="font10">any </span>
   <span class="font10">bias </span>
   <span class="font10">conducted </span>
   <span class="font10">effect </span>
   <span class="font10">infant </span>
   <span class="font10">low </span>
   <span class="font10">outcomes </span>
   <span class="font10">px; </span>
   <span class="font10">reducing </span>
   <span class="font10">use </span>
   <span class="font10">{font-family </span>
   <span class="font10">agent </span>
   <span class="font10">all </span>
   <span class="font10">are </span>
   <span class="font10">before </span>
   <span class="font10">evidence </span>
   <span class="font10">font-size </span>
   <span class="font10">not </span>
   <span class="font10">patients </span>
   <span class="font10">prior </span>
   <span class="font10">showed </span>
   <span class="font10">started </span>
   <span class="font10">study </span>
   <span class="font10">tenofovir </span>
   <span class="font10">this </span>
   <span class="font10">However, </span>
   <span class="font10">addition, </span>
   <span class="font10">but </span>
   <span class="font10">double; </span>
   <span class="font10">early </span>
   <span class="font10">early-middle </span>
   <span class="font10">included </span>
   <span class="font10">indicated </span>
   <span class="font10">middle </span>
   <span class="font10">months </span>
   <span class="font10">more </span>
   <span class="font10">obtain </span>
   <span class="font10">plot </span>
   <span class="font10">positive </span>
   <span class="font10">pregnancy. </span>
   <span class="font10">starting </span>
   <span class="font10">studies. </span>
   <span class="font10">untreated </span>
   <span class="font10">ALT </span>
   <span class="font10">Forest </span>
   <span class="font10">HBV. </span>
   <span class="font10">LDT </span>
   <span class="font10">Off </span>
   <span class="font10">S). </span>
   <span class="font10">based </span>
   <span class="font10">been </span>
   <span class="font10">border-color </span>
   <span class="font10">border-width </span>
   <span class="font10">completely </span>
   <span class="font10">controlled </span>
   <span class="font10">delivery </span>
   <span class="font10">earlier </span>
   <span class="font10">effective </span>
   <span class="font10">first, </span>
   <span class="font10">found </span>
   <span class="font10">gestation </span>
   <span class="font10">group, </span>
   <span class="font10">initiated </span>
   <span class="font10">initiation </span>
   <span class="font10">interrupting </span>
   <span class="font10">our </span>
   <span class="font10">pair-wised </span>
   <span class="font10">pooled </span>
   <span class="font10">prevention </span>
   <span class="font10">prospective </span>
   <span class="font10">rate </span>
   <span class="font10">received </span>
   <span class="font10">similar </span>
   <span class="font10">solid; </span>
   <span class="font10">studies, </span>
   <span class="font10">systematic </span>
   <span class="font10">used </span>
   <span class="font10">weeks </span>
   <span class="font10">{font-style </span>
   <span class="font10">{font-weight </span>
   <span class="font10">.Eâˆ’ </span>
   <span class="font10">Bayesian </span>
   <span class="font10">Commons </span>
   <span class="font10">Creative </span>
   <span class="font10">Efficacy </span>
   <span class="font10">Funding </span>
   <span class="font10">JL, </span>
   <span class="font10">Major </span>
   <span class="font10">National </span>
   <span class="font10">Network </span>
   <span class="font10">Science </span>
   <span class="font10">TC. </span>
   <span class="font10">TDF </span>
   <span class="font10">Therefore, </span>
   <span class="font10">This </span>
   <span class="font10">YW, </span>
   <span class="font10">[], </span>
   <span class="font10">administration </span>
   <span class="font10">al.Clinical </span>
   <span class="font10">appeared </span>
   <span class="font10">article </span>
   <span class="font10">associated </span>
   <span class="font10">better </span>
   <span class="font10">between </span>
   <span class="font10">blocking </span>
   <span class="font10">bold </span>
   <span class="font10">both </span>
   <span class="font10">comparing </span>
   <span class="font10">comparisons </span>
   <span class="font10">courier; </span>
   <span class="font10">decreasing </span>
   <span class="font10">disoproxil </span>
   <span class="font10">em; </span>
   <span class="font10">fumarate </span>
   <span class="font10">has </span>
   <span class="font10">improvement </span>
   <span class="font10">infants </span>
   <span class="font10">infection </span>
   <span class="font10">initiating </span>
   <span class="font10">load </span>
   <span class="font10">material </span>
   <span class="font10">nonrandomized </span>
   <span class="font10">others </span>
   <span class="font10">outcomes: </span>
   <span class="font10">performed </span>
   <span class="font10">positivity </span>
   <span class="font10">pregnancy: </span>
   <span class="font10">pt;} </span>
   <span class="font10">quality </span>
   <span class="font10">rare </span>
   <span class="font10">recommended </span>
   <span class="font10">reduce </span>
   <span class="font10">respectively </span>
   <span class="font10">review </span>
   <span class="font10">selection </span>
   <span class="font10">statistically </span>
   <span class="font10">superior </span>
   <span class="font10">supplementary </span>
   <span class="font10">their </span>
   <span class="font10">two </span>
  </p>
 </body>
</html>
